Market Insights Health Medical Technology Medical Devices

Dental Devices - Baltics

Baltics

The Dental Devices market market in the Baltics is expected to experience significant growth in the coming years.
By 2024, the projected revenue for this market is estimated to reach US$49.12m.
This growth is attributed to various factors, including advancements in dental technology, increasing awareness about oral health, and the rising demand for dental treatments.
Furthermore, the market is expected to maintain a steady growth rate.
The compound annual growth rate (CAGR) from 2024 to 2029 is projected to be 9.11%, which will result in a market volume of US$75.95m by 2029.
This growth indicates a positive trend in the Dental Devices market industry in the in Baltics.
In comparison to other countries, the United States is expected to generate the highest revenue in the global Dental Devices market.
In 2024, the projected revenue for the United States is estimated to be US$7,403.00m.
This highlights the strong market presence and economic power of the United States in the Dental Devices market industry.
Overall, the Dental Devices market in the in Baltics is poised for growth and offers opportunities for both domestic and international players in the industry.
With a projected increase in revenue and a favorable growth rate, the in Baltics' Dental Devices market is expected to contribute significantly to the global Dental Devices market industry.
Despite being a small market, the Baltic countries are experiencing a growing demand for advanced dental devices, driven by increasing awareness and investment in oral healthcare.

Key regions: Germany, Europe, Japan, Spain, Netherlands

Market

Region

Region comparison

Currency

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.